Previous single‐cell data analyses in an HPV16 E7 oncoprotein‐driven transgenic mouse model suggested a potential role for IL34‐CSF1R signalling in immune modulation, where low IL34 expression was associated with Langerhans cell dysfunction, and, in cervical cancer, with poor patient outcome. This evidence concerns the gene IL34 and cervical cancer.